TCT 233: One-year outcomes after CE-marked approved bicaval-valve system implantation in patients with severe tricuspid regurgitation.
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation